An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
Top Cited Papers
- 1 August 2008
- Vol. 26 (Suppl 10), K53-K61
- https://doi.org/10.1016/j.vaccine.2008.06.002
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Penetration of Colistin into Cerebrospinal FluidAntimicrobial Agents and Chemotherapy, 2009
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infectionsInternational Journal of Antimicrobial Agents, 2009
- 110 Years of the Meyer–Overton Rule: Predicting Membrane Permeability of Gases and Other Small CompoundsChemphyschem, 2009
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 2009
- Quantitative visualization of passive transport across bilayer lipid membranesProceedings of the National Academy of Sciences, 2008
- Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System PharmacotherapyPharmacological Reviews, 2008
- Plasma and Cerebrospinal Fluid Pharmacokinetics of Moxifloxacin in a Patient with Tuberculous MeningitisAntimicrobial Agents and Chemotherapy, 2008
- Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in FinlandBritish Journal of Cancer, 2007
- Pharmacokinetics of Intravenous Linezolid in Cerebrospinal Fluid and Plasma in Neurointensive Care Patients with Staphylococcal Ventriculitis Associated with External Ventricular DrainsAntimicrobial Agents and Chemotherapy, 2007
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006